Literature DB >> 6336548

Postoperative malignant hyperthermia episodes in patients who received "safe" anaesthetics.

R Grinberg1, G Edelist, A Gordon.   

Abstract

Three cases of postoperative malignant hyperthermia (MH) episodes, after what was considered to be a "safe" anaesthetic, are described. In each case the temperature rose in a delayed fashion after an uneventful anaesthetic. Treatment included intravenous dantrolene, surface cooling and ventilation with 100 per cent oxygen. Stress in the postoperative period may have been the triggering factor responsible for these reactions. Patients should be monitored well into the postoperative period as MH episodes may occur long after surgery is completed. If stress represents a significant triggering mechanism then no anaesthetic technique can be considered entirely safe.

Entities:  

Mesh:

Year:  1983        PMID: 6336548     DOI: 10.1007/bf03013807

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  5 in total

1.  The caffeine test of isolated human muscle in relation to malignant hyperthermia.

Authors:  W Kalow; B A Britt; A Richter
Journal:  Can Anaesth Soc J       Date:  1977-11

2.  Dantrolene and caffeine contracture test.

Authors:  W Lambert
Journal:  Can Anaesth Soc J       Date:  1980-05

3.  Advances in the diagnosis and treatment of malignant hyperthermia.

Authors:  J A Aldrete
Journal:  Acta Anaesthesiol Scand       Date:  1981-12       Impact factor: 2.105

4.  Malignant hyperthermia following preoperative oral administration of dantrolene.

Authors:  D C Fitzgibbons
Journal:  Anesthesiology       Date:  1981-01       Impact factor: 7.892

5.  Human malignant hyperthermia: awake episodes and correction by dantrolene.

Authors:  G A Gronert; R L Thompson; B M Onofrio
Journal:  Anesth Analg       Date:  1980-05       Impact factor: 5.108

  5 in total
  12 in total

1.  The anaesthetic management of the malignant hyperthermia susceptible parturient.

Authors:  M J Douglas; G H McMorland
Journal:  Can Anaesth Soc J       Date:  1986-05

2.  Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.

Authors:  A S Carr; J Lerman; M Cunliffe; M E McLeod; B A Britt
Journal:  Can J Anaesth       Date:  1995-04       Impact factor: 5.063

3.  Postoperative malignant hyperthermia.

Authors:  H Rosenberg; G A Gronert
Journal:  Can Anaesth Soc J       Date:  1984-01

4.  Diagnosis of malignant hyperthermia.

Authors:  D W Wingard
Journal:  Can Anaesth Soc J       Date:  1984-07

5.  Postoperative hyperthermia of unknown origin treated with dantrolene sodium.

Authors:  Hirohito Inada; Shigeharu Jinno; Hikaru Kohase; Haruhisa Fukayama; Masahiro Umino
Journal:  Anesth Prog       Date:  2005

Review 6.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546

7.  Postoperative malignant hyperthermia and dantrolene therapy.

Authors:  U Schulte-Sasse; W Hess; H J Eberlein
Journal:  Can Anaesth Soc J       Date:  1983-11

8.  Post-Operative Malignant Hyperthermia in a Child after Colon Interposition.

Authors:  Sevtap Hekimoğlu Şahin; Mustafa İnan; Burhan Aksu; Naci Öner; Alkin Çolak; Ahmet Güzel
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-12-01

9.  Novel Homozygous Missense Mutation in RYR1 Leads to Severe Congenital Ptosis, Ophthalmoplegia, and Scoliosis in the Absence of Myopathy.

Authors:  Nafi Dilaver; Neda Mazaheri; Reza Maroofian; Jawaher Zeighami; Tahere Seifi; Mina Zamani; Alireza Sedaghat; Gholam Reza Shariati; Hamid Galehdari
Journal:  Mol Syndromol       Date:  2017-11-15

10.  Malignant hyperthermia: a possible new variant.

Authors:  D S Lee; J P Adams; J E Zimmerman
Journal:  Can Anaesth Soc J       Date:  1985-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.